DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ: 067080)
South Korea flag South Korea · Delayed Price · Currency is KRW
19,500
+890 (4.78%)
Oct 11, 2024, 9:00 AM KST

DAE HWA Pharmaceutical Company Description

DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea.

The company offers drugs for anticancer, antibiotics, antifungal and skin ailment, antivirus, anti-allergosis, hemorrhoids, antidepressant, antiepileptic, psychotropic agent, anti respiratory, anti-inflammatory, analgesic, skeletal muscle relaxants, osteoporosis, anti-arthritis, gastro-intestinal, obesity, antispasmodic, diabetics, hypertension, hyperlipemia, antithrombotic and anticoagulant, hepatic, erectile dysfunction, urinary incontinence, prostatic hyperplasia, pregnancy, bug bite, anthelmintics, and cosmetic care, as well as vitamins and minerals, tonics, nutrition products.

It also provides transdermal drug delivery system, a pharmaceutical preparation that is applied to the intact skin for systemic absorption; and active pharmaceutical ingredients.

The company also exports its products to approximately 22 countries, including Asia, South America, the Middle East, and Africa.

DAE HWA Pharmaceutical Co., Ltd. was founded in 1984 and is headquartered in Seoul, South Korea.

DAE HWA Pharmaceutical Co., Ltd.
Country South Korea
Founded 1984
Industry Pharmaceutical Preparations
Employees 308
CEO Kim Eun-Seok

Contact Details

Address:
2145, Nambusunhwan-ro
Seoul
South Korea
Phone 82 2 6716 1071
Website dhpharm.co.kr

Stock Details

Ticker Symbol 067080
Exchange KOSDAQ
Fiscal Year January - December
Reporting Currency KRW
SIC Code 2834

Key Executives

Name Position
Kim Eun-Seok Chief Executive Officer